Last Price$3.7(6.6%)
Market Cap$253.4M
N/A
Peers median - 8.2%
(2,859.2%)
Peers median - 6.4%
16.9%
Peers median - 67.5%
(1,398.7%)
Peers median - 12.0%
Competing with CMPS
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$253.4M | 5.2 | $2.6 30.5% overvalued | (68.1%) | $3,682.8K | ($105.3M) | N/A | (2,859.2%) | 46.6% | (1,398.7%) | 16.9% | |
$78.9B | 6.3 | $368.8 18.5% undervalued | (0.1%) | $70.6B | $5,639.0M | 8.7% | 8.0% | 39.2% | 22.1% | 7.3% | |
$14.6B | 5.5 | $71.8 204.9% undervalued | 28.7% | €19.3B | €2,416.2M | (0.6%) | 12.5% | 24.6% | 3.8% | 69.6% | |
$12.2B | 6.7 | $329.6 130.3% undervalued | 13.8% | $12.8B | $1,470.3M | 5.6% | 11.5% | 48.9% | 11.8% | 544.4% | |
$12.0B | 6.0 | $378.2 203.6% undervalued | 32.9% | $20.7B | $1,116.0M | 0.6% | 5.4% | 35.6% | 10.2% | 154.1% | |
$11.7B | 6.2 | $315.7 79.6% undervalued | 1.0% | $15.8B | $1,123.3M | 10.8% | 7.1% | 51.2% | 15.6% | 73.3% | |
$10.0B | 5.6 | $72.1 27.8% overvalued | 34.3% | $5,373.2M | $280.2M | 11.9% | 5.2% | 29.3% | 11.2% | 12.4% | |
$8,767.7M | 7.0 | $397.3 32.8% overvalued | (6.2%) | $2,431.3M | $368.0M | 7.4% | 15.1% | 50.5% | 23.6% | 12.6% | |
$7,406.8M | 5.6 | $95.8 26.2% overvalued | 3.3% | $4,233.2M | $188.9M | 13.5% | 4.5% | 14.2% | 6.6% | 104.7% | |
$5,760.8M | 6.3 | $24.0 29.4% overvalued | 3.5% | $4,998.2M | $287.8M | 16.2% | 5.8% | 20.0% | 12.2% | 0.0% | |
$2,714.5M | 5.9 | $40.8 39.3% undervalued | (65.8%) | $3,154.0M | ($560.7M) | 7.7% | (17.8%) | 61.1% | 19.6% | 65.3% |
Compare CMPS Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
COMPASS Pathways plcCMPS
21.5x
N/A
7.4%
N/A
Median Peer Set
1.4x
7.6%
22.3%
7.2%
Acadia Healthcare Company, Inc.ACHC
1.5x
12.2%
N/A
(0.7%)
Chemed CorporationCHE
3.6x
6.1%
8.3%
12.0%
DaVita Inc.DVA
1.8x
5.6%
44.6%
7.3%
Encompass Health CorporationEHC
1.9x
11.9%
28.8%
8.5%
The Ensign Group, Inc.ENSG
2.1x
14.2%
39.9%
7.0%
Fresenius Medical Care AG & Co. KGaAFMS
1.2x
(0.6%)
7.7%
2.8%
HCA Healthcare, Inc.HCA
1.2x
8.7%
15.7%
8.2%
Option Care Health, Inc.OPCH
1.1x
9.1%
79.5%
6.2%
Tenet Healthcare CorporationTHC
1.1x
0.6%
613.3%
15.5%
Universal Health Services, Inc.UHS
1.0x
6.6%
12.1%
5.0%
Compare CMPS Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does COMPASS Pathways plc (CMPS) revenue growth compare to peers and the industry?
COMPASS Pathways plc (CMPS) revenue growth is N/A, compared to the peers' median of 8.2%.
2. How does COMPASS Pathways plc (CMPS) Free Cash Flow (FCF) margin compare to peers and the industry?
COMPASS Pathways plc (CMPS) FCF margin is (2,859.2%), compared to the peers' median of 6.4%.
3. How does COMPASS Pathways plc (CMPS) Total Debt to Equity ratio compare to peers and the industry?
COMPASS Pathways plc (CMPS) Total Debt to Equity ratio is 16.9%, compared to the peers' median of 67.5%.
4. How does COMPASS Pathways plc (CMPS) ROIC (Return on Invested Capital) compare to peers and the industry?
COMPASS Pathways plc (CMPS) ROIC is (1,398.7%), compared to the peers' median of 12.0%.